Business Context and Reporting Period
This Form 8-K Current Report was filed by Contango ORE, Inc. (CTGO) on May 6, 2024, covering events occurring on May 1 and May 2, 2024. The Company, incorporated in Delaware with principal offices in Fairbanks, Alaska, is a mining exploration company focused on gold assets in Alaska. The filing primarily discloses two material definitive agreements regarding the acquisition of assets and equity interests in other mining entities.
Key Financial Metrics and Transaction Values
The filing does not report standard periodic financial metrics such as revenue, net income, operating cash flow, or debt levels for a specific fiscal period. Instead, it details the financial terms of two proposed transactions:
- HighGold Acquisition: Total implied equity value of approximately $37 million. Consideration is an exchange of 0.019 shares of Contango common stock for each HighGold share, implying approximately $0.40 per HighGold share.
- Avidian Transaction: Initial consideration of $2,400,000, comprised of $400,000 in cash and $2,000,000 in Contango common stock. A contingent deferred payment of up to $1,000,000 is possible based on future production decisions.
Material Changes and Agreements
The Company entered into two significant agreements on May 1, 2024:
- HighGold Mining Inc. Acquisition: Contango intends to acquire 100% of HighGold Mining Inc. Upon completion, existing Contango shareholders will own approximately 85% of the combined entity, while HighGold shareholders will own approximately 15%. HighGold will be granted the right to appoint one director to Contango's board. Closing is expected in July 2024.
- Avidian Gold Alaska Inc. Acquisition: Contango agreed to purchase Avidian's 100% owned Alaskan subsidiary. The cash portion ($400,000) is payable in tranches: $50,000 deposit (paid), $150,000 at closing, and $200,000 within six months of closing. The equity portion is based on a 10-day VWAP prior to closing.
Outlook, Risks, and Contingencies
Guidance and Outlook: The Company expects both the HighGold Acquisition and the Avidian Transaction to close in July 2024, subject to customary closing conditions, shareholder approvals (specifically for Avidian), and regulatory approvals from the Toronto Venture Exchange and NYSE American.
Contingencies and Risks:
- Deferred Payments: The Avidian deal includes a potential $1,000,000 deferred payment if a positive production decision is made on the Amanita or Golden Zone properties within 120 months. If a third-party transaction occurs on these properties prior to a production decision, Avidian receives 20% of the consideration (capped at $500,000 per property).
- Termination Fees: If Avidian shareholders do not approve the transaction, the agreement terminates, and Avidian must pay Contango a $175,000 termination fee.
- Non-GAAP Measures: The Company issued a corporate presentation containing non-GAAP financial measures prepared by Kinross Gold Corporation (a partner in a joint venture). The filing states that reconciliations to GAAP are not included due to the difficulty of quantifying certain amounts and lack of access to detailed IFRS-based information.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from projections due to risks described in the Company's 10-K and 10-Q filings.
Investor Verification Checklist
- Verify the approval status of the HighGold and Avidian transactions by their respective shareholders and regulatory bodies (TSX Venture, NYSE American).
- Confirm the final share count for the equity consideration in the Avidian Transaction, as it depends on the 10-day VWAP immediately prior to closing.
- Review the full Arrangement Agreement (Exhibit 1.1) and Stock Purchase Agreement for specific indemnification provisions and closing conditions.
- Assess the impact of the 15% dilution to existing shareholders resulting from the HighGold Acquisition.
- Monitor the Company's ability to fund the cash tranches for the Avidian Transaction ($150,000 at closing and $200,000 within six months).